Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Alignment Healthcare Inc (NASDAQ: ALHC) was $16.62 for the day, up 3.55% from the previous closing price of $16.05. In other words, the price has increased by $3.55 from its previous closing price. On the day, 3.56 million shares were traded. ALHC stock price reached its highest trading level at $17.04 during the session, while it also had its lowest trading level at $16.01.
Ratios:
Our analysis of ALHC’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 2.34 whereas as Long-Term Debt/Eq ratio is at 2.34.
On July 31, 2025, Barclays Upgraded its rating to Equal Weight which previously was Underweight but kept the price unchanged to $13.
Stephens Upgraded its Equal-Weight to Overweight on December 03, 2024, whereas the target price for the stock was revised from $13 to $17.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 17 ’25 when General Atlantic (ALN HLTH), L sold 6,246,096 shares for $16.01 per share. The transaction valued at 99,999,997 led to the insider holds 24,596,079 shares of the business.
GENERAL ATLANTIC, L.P. sold 6,246,096 shares of ALHC for $99,999,997 on Sep 17 ’25. The Director now owns 24,596,079 shares after completing the transaction at $16.01 per share. On Sep 16 ’25, another insider, KONOWIECKI JOSEPH S, who serves as the Director of the company, sold 16,076 shares for $16.24 each. As a result, the insider received 261,074 and left with 1,110,973 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3291282432 and an Enterprise Value of 3117161216. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.99 while its Price-to-Book (P/B) ratio in mrq is 23.34. Its current Enterprise Value per Revenue stands at 0.934 whereas that against EBITDA is 396.283.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.19, which has changed by 0.5317973 over the last 52 weeks, in comparison to a change of 0.17904854 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $10.11. The 50-Day Moving Average of the stock is 7.21%, while the 200-Day Moving Average is calculated to be 10.41%.
Shares Statistics:
ALHC traded an average of 3.75M shares per day over the past three months and 3324710 shares per day over the past ten days. A total of 197.96M shares are outstanding, with a floating share count of 157.36M. Insiders hold about 20.54% of the company’s shares, while institutions hold 80.89% stake in the company. Shares short for ALHC as of 1757894400 were 12854317 with a Short Ratio of 3.43, compared to 1755216000 on 12063140. Therefore, it implies a Short% of Shares Outstanding of 12854317 and a Short% of Float of 10.0.
Earnings Estimates
Its stock is currently analyzed by 4.0 different market analysts. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.06.
Analysts are recommending an EPS of between $0.18 and $0.11 for the fiscal current year, implying an average EPS of $0.15. EPS for the following year is $0.32, with 4.0 analysts recommending between $0.4 and $0.26.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 10 analysts. It ranges from a high estimate of $983.6M to a low estimate of $978M. As of. The current estimate, Alignment Healthcare Inc’s year-ago sales were $692.43MFor the next quarter, 10 analysts are estimating revenue of $977.65M. There is a high estimate of $984.01M for the next quarter, whereas the lowest estimate is $968M.
A total of 10 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $3.91B, while the lowest revenue estimate was $3.89B, resulting in an average revenue estimate of $3.9B. In the same quarter a year ago, actual revenue was $2.7BBased on 10 analysts’ estimates, the company’s revenue will be $4.97B in the next fiscal year. The high estimate is $5.47B and the low estimate is $4.77B.
